US FDA approves Sanofi-AstraZeneca’s preventive RSV therapy for babies

(Reuters) -The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi and partner AstraZeneca’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers. The therapy, branded Beyfortus, was approved for preventing lower respiratory tract disease in infants born during or entering their first RSV season, and in children…

Read More

U.S. chip lobby presses Biden to refrain from further China curbs

By Stephen Nellis, Karen Freifeld and Andrea Shalal (Reuters) – The U.S.-based Semiconductor Industry Association trade group on Monday called on the Biden administration to “refrain from further restrictions” on chip sales to China as chief executives from the biggest U.S. semiconductor firms planned to visit Washington this week to press their views on China…

Read More

Brazil’s economic activity surprises negatively with 2% decline in May

BRASILIA (Reuters) – Economic activity in Brazil declined in May, showed a central bank index on Monday, signaling a non-linear trajectory for the country’s growth, even as analysts have been consistently revising their forecasts upward for the year. The IBC-BR economic activity index, a key gauge of gross domestic product (GDP), declined by a seasonally…

Read More